tirzepatide press release Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research Eli Lilly gets nod to

Those caused by infections include athletes foot, ringworm, and seborrheic dermatitis

GLP-1 drugs may end up being a major component of PCOS treatment, though theyre not yet FDA-approved for the condition

Your digestion is already slower on semaglutide, so respecting that natural shift in your diet makes a measurable difference in side effect tolerance

Heart benefits : For those living with heart disease who have overweight or obesity, Wegovy has been shown to reduce the risk of cardiovascular events like heart attack and stroke and was approved in 2024 for that use

The elucidation of the Warburg effect has significantly advanced our comprehension of lactate metabolism [16]

Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion